Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia J Simner

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Frontiers in Microbiology|August 25, 2022
Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among <i>Enterobacteriaceae</i>Rick Conzemius, Yehudit Bergman, Peter Májek, et al.
Journal of Clinical Microbiology|June 30, 2025
Establishing Clinical and Laboratory Standards Institute M45 antimicrobial susceptibility testing methods and breakpoints for <i>Pseudomonas</i> other than <i>Pseudomonas aeruginosa</i>Patricia J Simner, Harley Harris, Emily Jacobs, et al.
Journal of Clinical Microbiology|October 12, 2023
Reply to "Letter responding to performance of updated <i>Enterobacterales</i> piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system"Romney M Humphries, April N Abbott, Kevin Alby, et al.
American Journal of Clinical Pathology|September 20, 2021
Case Report and Genomic Analysis of Cefiderocol-Resistant Escherichia coli Clinical IsolatesTravis K Price, Kusha Davar, Deisy Contreras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2022
Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood CulturesPatricia J Simner, Jennifer Dien Bard, Christopher Doern, et al.
Journal of Clinical Microbiology|July 5, 2019
Multicenter Clinical Validation of the Molecular BD Max Enteric Viral Panel for Detection of Enteric PathogensWilliam Stokes, Patricia J Simner, Joel Mortensen, et al.
Journal of Clinical Microbiology|March 22, 2023
Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee AdvisoryPatricia J Simner, Elizabeth L Palavecino, Michael J Satlin, et al.
Open Forum Infectious Diseases|October 23, 2025
Investigating the Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Among Patients Admitted to the Intensive Care UnitSima L Sharara, Patricia J Simner, Yehudit Bergman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2021
Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene ExpressionPatricia J Simner, Heba H Mostafa, Yehudit Bergman, et al.
Journal of Clinical Microbiology|April 22, 2025
Evaluation of long-read 16S rRNA next-generation sequencing for identification of bacterial isolates in a clinical diagnostic laboratoryVictoria L Campodónico, Jean Ruelle, Anna Fitzgerald, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Frontiers in Microbiology|August 25, 2022
Automated antimicrobial susceptibility testing and antimicrobial resistance genotyping using Illumina and Oxford Nanopore Technologies sequencing data among <i>Enterobacteriaceae</i>Rick Conzemius, Yehudit Bergman, Peter Májek, et al.
Journal of Clinical Microbiology|June 30, 2025
Establishing Clinical and Laboratory Standards Institute M45 antimicrobial susceptibility testing methods and breakpoints for <i>Pseudomonas</i> other than <i>Pseudomonas aeruginosa</i>Patricia J Simner, Harley Harris, Emily Jacobs, et al.
Journal of Clinical Microbiology|October 12, 2023
Reply to "Letter responding to performance of updated <i>Enterobacterales</i> piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system"Romney M Humphries, April N Abbott, Kevin Alby, et al.
American Journal of Clinical Pathology|September 20, 2021
Case Report and Genomic Analysis of Cefiderocol-Resistant Escherichia coli Clinical IsolatesTravis K Price, Kusha Davar, Deisy Contreras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2022
Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood CulturesPatricia J Simner, Jennifer Dien Bard, Christopher Doern, et al.
Journal of Clinical Microbiology|July 5, 2019
Multicenter Clinical Validation of the Molecular BD Max Enteric Viral Panel for Detection of Enteric PathogensWilliam Stokes, Patricia J Simner, Joel Mortensen, et al.
Journal of Clinical Microbiology|March 22, 2023
Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee AdvisoryPatricia J Simner, Elizabeth L Palavecino, Michael J Satlin, et al.
Open Forum Infectious Diseases|October 23, 2025
Investigating the Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Among Patients Admitted to the Intensive Care UnitSima L Sharara, Patricia J Simner, Yehudit Bergman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2021
Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene ExpressionPatricia J Simner, Heba H Mostafa, Yehudit Bergman, et al.
Journal of Clinical Microbiology|April 22, 2025
Evaluation of long-read 16S rRNA next-generation sequencing for identification of bacterial isolates in a clinical diagnostic laboratoryVictoria L Campodónico, Jean Ruelle, Anna Fitzgerald, et al.
Pageof 16